938066-21-8

Basic information

• Product Name: 2-(1-Methyl-1H-pyrazol-5-yl)pyridine
• Synonyms: 2-(1-Methyl-1H-pyrazol-5-yl)pyridine
• CAS NO: 938066-21-8
• Molecular Formula: C9H9N3
• Molecular Weight: 159.18786
• Mol File: 938066-21-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 295 °C at 760 mmHg
• Flash Point: 132.2 °C
• Appearance: /
• Density: 1.13 g/cm³
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 2-(1-Methyl-1H-pyrazol-5-yl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1-Methyl-1H-pyrazol-5-yl)pyridine(938066-21-8)
• EPA Substance Registry System: 2-(1-Methyl-1H-pyrazol-5-yl)pyridine(938066-21-8)

Safety Data

• Hazardous Substances Data: 938066-21-8(Hazardous Substances Data)

Usage

General Description

2-(1-Methyl-1H-pyrazol-5-yl)pyridine, also known as MPP, is a chemical compound with the molecular formula C11H10N4. It is a heterocyclic aromatic organic compound that is commonly used in the synthesis of pharmaceuticals and agrochemicals. MPP has a pyridine ring attached to a pyrazole ring, with a methyl group at the 1 position of the pyrazole ring. It is a versatile building block in organic synthesis and can be used in the preparation of a variety of biologically active compounds. MPP is also used as a ligand in coordination chemistry and has potential applications in the field of material science.

Upstream product

• 66521-54-8 3-(dimethylamino)-1-(pyridine-2-yl)prop-2-en-1-one 
• 60-34-4 methylhydrazine 
• 75415-00-8 (Z)-3-(dimethylamino)-1-(pyridin-2-yl)prop-2-en-1-one 
• 5029-67-4 2-iodopyridine 
• 34091-51-5 5-iodo-1-methyl-1H-pyrazole 
• 109-04-6 2-bromo-pyridine 
• 847818-74-0 1-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole 

Relevant articles and documents

MTA-Cooperative PRMT5 Inhibitors

The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Pyrazole-based ligands for the [copper-TEMPO]-mediated oxidation of benzyl alcohol to benzaldehyde and structures of the Cu coordination compounds

New pyrazole-based ligands have been designed, and the catalytic performances of their copper(II) complexes for the [copper/TEMPO]-mediated oxidation of benzyl alcohol to benzaldehyde have been examined. The pyridine-pyrazole ligands give efficient catalysts, while the use of naphthol-pyrazole ligands results in inactive catalytic systems. Single-crystals of four Cu coordination compounds obtained from pyridine-pyrazole ligands and a free ligand have been isolated and were characterized by X-ray diffraction. Thus, the solid-state structures of three copper(II) complexes are described, together with a copper(I) coordination chain, exhibiting luminescent properties. Wiley-VCH Verlag GmbH & Co. KGaA, 2007.